Literature DB >> 29182987

Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.

Yasuhiko Kubota1, Aaron R Folsom2, Christie M Ballantyne3, Weihong Tang2.   

Abstract

BACKGROUND AND AIMS: No prospective study has investigated whether elevated lipoprotein(a) concentrations are associated with an increased risk of abdominal aortic aneurysm (AAA). We aimed to prospectively investigate this association.
METHODS: In 1987-1989, the Atherosclerosis Risk in Communities study measured plasma lipoprotein(a) in 13,683 participants aged 45-64 years, without a history of AAA surgery. We followed them for incident, clinical AAA events through 2011.
RESULTS: During the 272,914 person-years of follow-up, over a median of 22.6 years, we documented 505 incident AAA events. The age-, sex-, and race-adjusted model showed that individuals in the highest quintile of plasma lipoprotein(a) had an increased risk of AAA. Further adjustment for the other potential confounding factors, including other plasma lipids (high- and low-density lipoprotein cholesterol and triglyceride concentrations), attenuated the association, but individuals in the highest versus lowest quintile of plasma lipoprotein(a) still had a significantly increased risk of AAA [hazard ratio (95% confidence interval): 1.57 (1.19-2.08)]. Interaction testing suggested no difference in the associations for whites and African Americans (p for interaction = 0.96). A restricted cubic spline analysis demonstrated a positive dose-response relation of plasma lipoprotein(a) with AAA, with a steep increase in AAA risk above the 75th percentile (p for overall association = 0.0086, p for non-linear association = 0.097).
CONCLUSIONS: In this population-based cohort study, elevated lipoprotein(a) concentrations were independently associated with an increased risk of AAA. The association reflected a threshold of increased AAA risk at high lipoprotein(a) concentrations, rather than a steady monotonic association.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Lipoprotein(a); Population-based study; Prospective study

Mesh:

Substances:

Year:  2017        PMID: 29182987      PMCID: PMC5788200          DOI: 10.1016/j.atherosclerosis.2017.10.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  31 in total

Review 1.  Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

Authors:  Adam Taleb; Joseph L Witztum; Sotirios Tsimikas
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

2.  Screening for abdominal aortic aneurysm: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-02-01       Impact factor: 25.391

3.  Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

4.  Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm.

Authors:  Kazuhiko Kotani; Amirhossein Sahebkar; Maria-Corina Serban; Sorin Ursoniu; Dimitri P Mikhailidis; Giovanni Mariscalco; Steven R Jones; Seth Martin; Michael J Blaha; Peter P Toth; Manfredi Rizzo; Karam Kostner; Jacek Rysz; Maciej Banach
Journal:  Angiology       Date:  2016-09-29       Impact factor: 3.619

5.  Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.

Authors:  Haralampos J Milionis; Theodosios D Filippatos; Tsironis Loukas; Eleni T Bairaktari; Alexandros D Tselepis; Moses S Elisaf
Journal:  Atherosclerosis       Date:  2005-09-28       Impact factor: 5.162

6.  Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Weihong Tang; Lu Yao; Nicholas S Roetker; Alvaro Alonso; Pamela L Lutsey; Carol C Steenson; Frank A Lederle; David W Hunter; Lindsay G S Bengtson; Weihua Guan; Emil Missov; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-11-10       Impact factor: 8.311

7.  Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Tetsuya Ohira; Pamela J Schreiner; Joel D Morrisett; Lloyd E Chambless; Wayne D Rosamond; Aaron R Folsom
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

8.  Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail.

Authors:  F Kronenberg; E Trenkwalder; H Dieplinger; G Utermann
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-12       Impact factor: 8.311

9.  Isolation and characterization of the two major apoproteins in human lipoprotein [a].

Authors:  J W Gaubatz; M V Chari; M L Nava; J R Guyton; J D Morrisett
Journal:  J Lipid Res       Date:  1987-01       Impact factor: 5.922

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  7 in total

1.  The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study.

Authors:  Weihong Tang; Lu Yao; Ron C Hoogeveen; Alvaro Alonso; David J Couper; Pamela L Lutsey; Carol C Steenson; Weihua Guan; David W Hunter; Frank A Lederle; Aaron R Folsom
Journal:  Angiology       Date:  2018-06-26       Impact factor: 3.619

2.  Systems Approach to Study Associations between OxLDL and Abdominal Aortic Aneurysms.

Authors:  Łukasz Gutowski; Kaja Gutowska; Maria Pioruńska-Stolzmann; Piotr Formanowicz; Dorota Formanowicz
Journal:  Int J Mol Sci       Date:  2019-08-11       Impact factor: 5.923

Review 3.  Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma.

Authors:  Luca Esposito; Marco Di Maio; Angelo Silverio; Francesco Paolo Cancro; Michele Bellino; Tiziana Attisano; Fabio Felice Tarantino; Giovanni Esposito; Carmine Vecchione; Gennaro Galasso; Cesare Baldi
Journal:  Front Cardiovasc Med       Date:  2022-02-04

4.  Association of cardiovascular risk factors and lifestyle behaviors with aortic aneurysm: A Mendelian randomization study.

Authors:  Jiawei Zhou; Jianfeng Lin; Yuehong Zheng
Journal:  Front Genet       Date:  2022-08-08       Impact factor: 4.772

5.  Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative.

Authors:  Elizabeth L Chou; Mary Pettinger; Bernhard Haring; Matthew W Mell; Mark A Hlatky; Jean Wactawski-Wende; Matthew A Allison; Robert A Wild; Aladdin H Shadyab; Robert B Wallace; Linda G Snetselaar; Matthew J Eagleton; Mark F Conrad; Simin Liu
Journal:  J Vasc Surg       Date:  2020-08-31       Impact factor: 4.268

6.  Associations of Genetically Predicted Lp(a) (Lipoprotein [a]) Levels With Cardiovascular Traits in Individuals of European and African Ancestry.

Authors:  Benjamin A Satterfield; Ozan Dikilitas; Maya S Safarova; Shoa L Clarke; Catherine Tcheandjieu; Xiang Zhu; Lisa Bastarache; Eric B Larson; Anne E Justice; Ning Shang; Elisabeth A Rosenthal; Amy Sanghavi Shah; Bahram Namjou-Khales; Elaine M Urbina; Wei-Qi Wei; QiPing Feng; Gail P Jarvik; Scott J Hebbring; Mariza de Andrade; Teri A Manolio; Themistocles L Assimes; Iftikhar J Kullo
Journal:  Circ Genom Precis Med       Date:  2021-07-20

7.  Is Lipoprotein (a) a Risk Factor for Coronary Artery Ectasia?

Authors:  Hanna K Al-Makhamreh; Ala' E Shaban; Sofia S AlHaddadin; Abedallatif A AlSharif; Ruba A Ghalayni; Lana F Daoud; Baha M Alshraideh
Journal:  Cardiol Res       Date:  2020-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.